Filgrastim biosimilar (Center of Molecular Immunology)
非格司亭生物类似药（Center of Molecular Immunology）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameFilgrastim biosimilar (Center of Molecular Immunology)
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2016/01/14
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCenter Of Molecular Immunology
China Registration ClassN/A
Develop Information
Active CompaniesCenter Of Molecular Immunology
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A